Human serum albumin binding and synergistic effects of gefitinib in combination with regorafenib on colorectal cancer cell lines
作者： Hamid Tanzadehpanah , Hanie Mahaki , Mohammadreza Moradi , Saeid Afshar , Omid Rajabi
关键词:
摘要:
futuremedicine.com 
sci-hub.se 参考文章(43)
SA Bustin, Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. Journal of Molecular Endocrinology. ,vol. 29, pp. 23- 39 ,(2002) , 10.1677/JME.0.0290023
Harald Schnidar, Markus Eberl, Stefan Klingler, Doris Mangelberger, Maria Kasper, Cornelia Hauser-Kronberger, Gerhard Regl, Renate Kroismayr, Richard Moriggl, Maria Sibilia, Fritz Aberger, Epidermal Growth Factor Receptor Signaling Synergizes with Hedgehog/GLI in Oncogenic Transformation via Activation of the MEK/ERK/JUN Pathway Cancer Research. ,vol. 69, pp. 1284- 1292 ,(2009) , 10.1158/0008-5472.CAN-08-2331
Yu Fan, Bing Shen, Mingyue Tan, Xinyu Mu, Yan Qin, Fang Zhang, Yong Liu, TGF-β–Induced Upregulation of malat1 Promotes Bladder Cancer Metastasis by Associating with suz12 Clinical Cancer Research. ,vol. 20, pp. 1531- 1541 ,(2014) , 10.1158/1078-0432.CCR-13-1455
Daniel J. Crona, Meredith D. Keisler, Christine M. Walko, Regorafenib A Novel Multitargeted Tyrosine Kinase Inhibitor for Colorectal Cancer and Gastrointestinal Stromal Tumors Annals of Pharmacotherapy. ,vol. 47, pp. 1685- 1696 ,(2013) , 10.1177/1060028013509792
Eswaran Devarajan, Aysegul A Sahin, Jack S Chen, Raghu R Krishnamurthy, Neeraj Aggarwal, Anne-Marie Brun, Anna Sapino, Fan Zhang, Dhawal Sharma, Xiao-He Yang, Ann D Tora, Kapil Mehta, Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance Oncogene. ,vol. 21, pp. 8843- 8851 ,(2002) , 10.1038/SJ.ONC.1206044
Teresa Troiani, Owen Lockerbie, Mark Morrow, Fortunato Ciardiello, S. Gail Eckhardt, Sequence-dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases Molecular Cancer Therapeutics. ,vol. 5, pp. 1883- 1894 ,(2006) , 10.1158/1535-7163.MCT-06-0055
F Ciardiello, T Troiani, F Caputo, M De Laurentiis, G Tortora, G Palmieri, F De Vita, M R Diadema, M Orditura, G Colantuoni, C Gridelli, G Catalano, S De Placido, A R Bianco, Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer British Journal of Cancer. ,vol. 94, pp. 1604- 1609 ,(2006) , 10.1038/SJ.BJC.6603141
Shan Huang, Shushu Peng, Fawei Zhu, Xiaolin Lei, Qi Xiao, Wei Su, Yi Liu, Chusheng Huang, Lixia Zhang, Multispectroscopic Investigation of the Interaction Between two Ruthenium(II) Arene Complexes of Curcumin Analogs and Human Serum Albumin Biological Trace Element Research. ,vol. 169, pp. 189- 203 ,(2016) , 10.1007/S12011-015-0416-2
Wen‑Jie Cai, Ming‑Jie Wang, Li‑Hua Ju, Cheng Wang, Yi‑Chun Zhu, Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21. Cell Biology International. ,vol. 34, pp. 565- 572 ,(2010) , 10.1042/CBI20090368
Alex A. Adjei, Julian R. Molina, Sumithra J. Mandrekar, Randolph Marks, Joel R. Reid, Gary Croghan, Lorelei J. Hanson, James R. Jett, Chenghua Xia, Chetan Lathia, Ronit Simantov, Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer Clinical Cancer Research. ,vol. 13, pp. 2684- 2691 ,(2007) , 10.1158/1078-0432.CCR-06-2889